Auto Ancillary · Founded 1863 · www.bbtcl.com · BSE 501425 · NSE BOM.BURMAH · ISIN INE050A01025
No Notes Added Yet
Business
Bombay Burmah Trading Corporation Ltd. (BBTC) is primarily a diversified holding company with a rich history, part of the Wadia Group. While its listed sector is "Auto Ancillary," its core business model involves direct operations and significant investments in a wide array of sectors, including plantations (tea, coffee, timber), foods (through its associate Britannia Industries Ltd.), chemicals (through its subsidiary National Peroxide Ltd.), and engineering. The company generates revenue directly from its plantation and engineering operations, and indirectly through dividends and share of profits from its significant associate and subsidiary companies. It acts as an investment vehicle for the Wadia Group's diverse interests.
Revenue Mix
BBTC's revenue mix is highly diversified across several key segments:
Plantations: Direct operations in tea (e.g., across South India) and coffee. Also has interests in timber and other agricultural products.
Foods: Significant strategic investment in Britannia Industries Ltd. (a leading Indian food company), contributing a substantial portion of its reported profits (share of associate's profit).
Chemicals: Operations through its subsidiary National Peroxide Ltd., engaged in the manufacturing of hydrogen peroxide.
Engineering: Involved in precision springs, cutting tools, and other engineering products.
Other Investments: Various other smaller strategic investments and holdings across different industries.
Note: Specific revenue contributions by percentage for each segment are not typically disclosed in a granular format publicly for holding companies but profits are largely driven by its stake in Britannia.
Industry
BBTC does not operate as a direct competitor in a single industry. Instead, it functions as a conglomerate or diversified holding company. Its positioning is unique as it participates across multiple industries through its direct operations and strategic investments.
Plantations: Competes with other large plantation companies, facing commodity price volatility and weather-related risks.
Foods (via Britannia): Britannia is a market leader in biscuits and other baked goods, competing with major FMCG players like Parle, ITC, and Mondelez.
Chemicals (via National Peroxide): A key player in the hydrogen peroxide market in India, competing with a few other domestic and international manufacturers.
Given its diversified nature, BBTC's overall positioning is as a long-term strategic investor and operator across varied sectors, leveraging its historical presence and Wadia Group association.
MOAT
BBTC's competitive advantages are primarily derived from the strengths of its underlying assets and strategic investments:
Brand Equity & Market Leadership (Indirect): Its significant stake in Britannia Industries provides exposure to a strong brand, extensive distribution network, and market leadership in various food categories.
Land Bank & Heritage: Long-standing presence in plantations offers substantial land holdings and historical expertise.
Established Market Position (Chemicals): National Peroxide holds a strong position in the Indian hydrogen peroxide market, benefiting from established relationships and technical know-how.
Diversification: The broad portfolio of businesses, while complex, provides resilience against downturns in any single sector.
Promoter Strength: Being part of the Wadia Group provides access to capital, strategic guidance, and a strong business lineage.
Growth Drivers
Performance of Britannia: Continued growth in demand for Britannia's food products, market share gains, and expansion into new categories will significantly drive BBTC's profitability.
Agricultural Commodity Price Trends: Favorable global and domestic prices for tea, coffee, and timber can enhance revenues and profitability from its direct plantation operations.
Industrial Growth (Chemicals & Engineering): Increased demand from end-user industries for hydrogen peroxide (textiles, paper & pulp, pharma) and precision engineering products will benefit these segments.
Value Unlocking: Potential for consolidation, divestment of non-core assets, or strategic realignments within its diverse portfolio to unlock shareholder value.
Efficiency Improvements: Operational improvements and cost optimization across its direct businesses.
Risks
Holding Company Discount: As a diversified holding company, BBTC's market valuation often trades at a discount to the sum of its underlying asset values, making value realization challenging.
Commodity Price Volatility: Its plantation business is exposed to fluctuations in global tea, coffee, and timber prices, as well as weather-related risks affecting crop yields.
Regulatory & Environmental Risks: Changes in agricultural policies, labor laws, and environmental regulations can impact plantation and chemical operations.
Competition: Intense competition in the food (Britannia), chemical, and engineering sectors can impact growth and margins of its associates/subsidiaries.
Dependency on Associates: A significant portion of its reported profitability is tied to the performance of Britannia Industries, making it susceptible to risks faced by Britannia.
Economic Slowdown: A general economic slowdown in India can impact consumer spending (affecting Britannia) and industrial demand (affecting chemicals and engineering).
Management & Ownership
BBTC is a flagship company of the Wadia Group, one of India's oldest and most respected business houses. The company is promoted and controlled by the Wadia family. The management typically comprises experienced professionals with long tenures, often overseen by the promoter family. The ownership structure reflects the Wadia Group's significant stake, ensuring strategic control and long-term vision. The Wadia Group is known for its diversified business interests across textiles, aviation, real estate, and consumer goods.
Outlook
BBTC presents a complex investment profile due to its diversified nature and holding company structure. The bull case rests on the continued strong performance and growth of its key associate, Britannia Industries, and the potential for long-term value creation from its established plantation assets and steady chemical business. There's also a possibility of value unlocking initiatives by the Wadia Group in the future. However, the bear case highlights the persistent holding company discount, the inherent complexity of managing a diverse portfolio across cyclical industries, and exposure to commodity price volatility in its direct operations. While its diversified structure offers stability, it also requires navigating varied industry-specific challenges. Its future trajectory will largely depend on the performance of its core investments, particularly Britannia, combined with strategic capital allocation and operational efficiency across its direct businesses.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 4337 | 4162 | 4333 | 4761 | 4685 | 4519 | 4712 | 4943 | 5066 | 4818 |
| Other Income | 54 | 76 | 70 | 76 | 74 | 49 | 72 | 81 | 75 | 86 |
| Total Income | 4390 | 4237 | 4403 | 4837 | 4759 | 4568 | 4784 | 5024 | 5141 | 4904 |
| Total Expenditure | 3538 | 3399 | 3598 | 4037 | 3811 | 3717 | 3988 | 4004 | 4116 | 3985 |
| Operating Profit | 853 | 839 | 806 | 800 | 948 | 851 | 796 | 1020 | 1025 | 919 |
| Interest | 53 | 29 | 31 | 37 | 51 | 39 | 34 | 41 | 39 | 24 |
| Depreciation | 81 | 84 | 77 | 80 | 86 | 84 | 86 | 89 | 88 | 89 |
| Exceptional Income / Expenses | -3 | 0 | -48 | -1 | -22 | 59 | 0 | 3 | 3 | 88 |
| Profit Before Tax | 716 | 726 | 649 | 682 | 789 | 787 | 677 | 893 | 900 | 894 |
| Provision for Tax | 203 | 207 | 185 | 279 | 191 | 203 | 180 | 325 | 238 | 108 |
| Profit After Tax | 513 | 519 | 465 | 403 | 599 | 584 | 496 | 568 | 662 | 786 |
| Adjustments | -126 | -235 | -242 | -151 | -260 | -275 | -256 | -327 | -346 | -342 |
| Profit After Adjustments | 387 | 284 | 222 | 253 | 339 | 309 | 241 | 242 | 316 | 444 |
| Adjusted Earnings Per Share | 55.4 | 40.7 | 31.9 | 36.2 | 48.6 | 44.3 | 34.5 | 34.6 | 45.4 | 63.7 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 8197 | 8762 | 9434 | 10238 | 11423 | 11889 | 13396 | 14507 | 16623 | 17109 | 18298 | 19539 |
| Other Income | 155 | 160 | 195 | 201 | 225 | 327 | 339 | 367 | 471 | 398 | 269 | 314 |
| Total Income | 8352 | 8922 | 9629 | 10439 | 11648 | 12216 | 13735 | 14874 | 17094 | 17507 | 18567 | 19853 |
| Total Expenditure | 7342 | 7558 | 8173 | 8800 | 9741 | 10141 | 10982 | 12297 | 13839 | 14009 | 15162 | 16093 |
| Operating Profit | 1010 | 1364 | 1456 | 1639 | 1908 | 2076 | 2753 | 2577 | 3255 | 3498 | 3405 | 3760 |
| Interest | 41 | 44 | 43 | 55 | 60 | 124 | 151 | 252 | 425 | 364 | 159 | 138 |
| Depreciation | 155 | 126 | 131 | 153 | 173 | 200 | 213 | 213 | 239 | 313 | 327 | 352 |
| Exceptional Income / Expenses | 146 | 0 | 0 | 0 | 0 | -17 | -1 | 10 | -1490 | -106 | -12 | 94 |
| Profit Before Tax | 961 | 1195 | 1282 | 1312 | 1841 | 1868 | 2124 | 1507 | 42 | 2481 | 3057 | 3364 |
| Provision for Tax | 265 | 403 | 423 | 539 | 652 | 587 | 847 | 706 | 814 | 790 | 857 | 851 |
| Profit After Tax | 696 | 792 | 858 | 773 | 1189 | 1280 | 1278 | 801 | -772 | 1692 | 2199 | 2512 |
| Adjustments | -339 | -406 | -437 | -495 | -569 | -682 | -908 | -738 | -904 | -1055 | -1077 | -1271 |
| Profit After Adjustments | 357 | 386 | 422 | 277 | 621 | 598 | 370 | 63 | -1676 | 637 | 1123 | 1243 |
| Adjusted Earnings Per Share | 51.1 | 55.4 | 60.4 | 39.8 | 89 | 85.7 | 53 | 9.1 | -240.2 | 91.2 | 160.9 | 178.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | 8% | 9% | 8% |
| Operating Profit CAGR | -3% | 10% | 10% | 13% |
| PAT CAGR | 30% | 40% | 11% | 12% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -26% | 15% | 2% | 14% |
| ROE Average | 43% | 22% | 21% | 28% |
| ROCE Average | 46% | 28% | 26% | 32% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1566 | 1913 | 3678 | 3964 | 4417 | 5094 | 5476 | 5497 | 4032 | 4628 | 5632 |
| Minority's Interest | 738 | 1067 | 1342 | 1703 | 2143 | 2212 | 1795 | 1296 | 1781 | 1975 | 2181 |
| Borrowings | 506 | 306 | 587 | 610 | 472 | 770 | 1127 | 3558 | 4271 | 911 | 713 |
| Other Non-Current Liabilities | 4 | 11 | 37 | 35 | 62 | 82 | 136 | 95 | 148 | 88 | 112 |
| Total Current Liabilities | 1655 | 1827 | 1744 | 2015 | 2320 | 3172 | 3884 | 4805 | 5441 | 4262 | 4048 |
| Total Liabilities | 4470 | 5125 | 7389 | 8327 | 9415 | 11329 | 12418 | 15251 | 15677 | 11868 | 12687 |
| Fixed Assets | 1878 | 1989 | 2202 | 2357 | 2702 | 2875 | 2788 | 2749 | 3597 | 3724 | 3851 |
| Other Non-Current Assets | 450 | 943 | 2455 | 2416 | 2750 | 4311 | 3635 | 3816 | 3620 | 2923 | 4490 |
| Total Current Assets | 2142 | 2193 | 2732 | 3553 | 3963 | 4144 | 5995 | 8686 | 8415 | 5214 | 4346 |
| Total Assets | 4470 | 5125 | 7389 | 8327 | 9415 | 11329 | 12418 | 15251 | 15677 | 11868 | 12687 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 154 | 315 | 120 | 147 | 173 | 137 | 171 | 603 | 590 | 540 | 742 |
| Cash Flow from Operating Activities | 656 | 786 | 411 | 1213 | 1104 | 1409 | 1692 | 1447 | 2475 | 1935 | 2278 |
| Cash Flow from Investing Activities | -435 | -662 | -357 | -967 | -775 | -1649 | -391 | -2997 | -1829 | 3884 | -902 |
| Cash Flow from Financing Activities | -59 | -304 | -26 | -221 | -368 | 267 | -866 | 1494 | -705 | -5648 | -1844 |
| Net Cash Inflow / Outflow | 162 | -180 | 27 | 26 | -39 | 27 | 435 | -55 | -60 | 172 | -469 |
| Closing Cash & Cash Equivalent | 315 | 130 | 147 | 173 | 137 | 171 | 603 | 551 | 540 | 739 | 271 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 51.15 | 55.37 | 60.45 | 39.76 | 88.99 | 85.75 | 52.96 | 9.09 | -240.22 | 91.24 | 160.9 |
| CEPS(Rs) | 121.94 | 131.59 | 141.79 | 132.74 | 195.2 | 212.16 | 213.62 | 145.29 | -76.31 | 287.36 | 362.02 |
| DPS(Rs) | 1 | 1 | 1 | 1 | 1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 17 |
| Book NAV/Share(Rs) | 223.86 | 274.17 | 526.78 | 567.25 | 631.64 | 727.63 | 782.85 | 787.79 | 577.92 | 663.35 | 807.16 |
| Core EBITDA Margin(%) | 10.21 | 13.38 | 12.98 | 13.34 | 13.99 | 15.54 | 17.22 | 14.6 | 16.02 | 17.25 | 16.33 |
| EBIT Margin(%) | 11.96 | 13.76 | 13.65 | 12.67 | 15.81 | 17.7 | 16.23 | 11.62 | 2.69 | 15.83 | 16.75 |
| Pre Tax Margin(%) | 11.48 | 13.28 | 13.2 | 12.16 | 15.31 | 16.6 | 15.15 | 9.95 | 0.24 | 13.81 | 15.92 |
| PAT Margin (%) | 8.31 | 8.8 | 8.84 | 7.16 | 9.89 | 11.38 | 9.11 | 5.29 | -4.44 | 9.41 | 11.45 |
| Cash Profit Margin (%) | 10.16 | 10.2 | 10.19 | 8.59 | 11.32 | 13.16 | 10.63 | 6.7 | -3.06 | 11.16 | 13.15 |
| ROA(%) | 17.07 | 16.51 | 13.72 | 9.83 | 13.41 | 12.34 | 10.76 | 5.79 | -4.99 | 12.28 | 17.91 |
| ROE(%) | 48.8 | 45.59 | 30.73 | 20.24 | 28.44 | 27 | 24.25 | 14.62 | -16.2 | 39.06 | 42.87 |
| ROCE(%) | 44.29 | 48.09 | 35.83 | 28.24 | 36.71 | 31.83 | 29.81 | 18.06 | 4.27 | 32.87 | 46.17 |
| Receivable days | 8.14 | 8.8 | 8.69 | 10.01 | 12.45 | 13.42 | 8.86 | 8.5 | 8.22 | 8.66 | 9.29 |
| Inventory Days | 22.47 | 21.55 | 24.06 | 24.73 | 24.41 | 27.85 | 26.27 | 31.56 | 28.36 | 25.49 | 24.21 |
| Payable days | 50.36 | 54.98 | 50.96 | 53.09 | 59.77 | 58.22 | 57.34 | 54.63 | 52.33 | 59.32 | 58.45 |
| PER(x) | 8.59 | 6.65 | 14.16 | 29.4 | 14.63 | 8.54 | 20.97 | 94.66 | 0 | 17.17 | 10.99 |
| Price/Book(x) | 1.96 | 1.34 | 1.62 | 2.06 | 2.06 | 1.01 | 1.42 | 1.09 | 1.4 | 2.36 | 2.19 |
| Dividend Yield(%) | 0.23 | 0.27 | 0.12 | 0.09 | 0.08 | 0.16 | 0.11 | 0.14 | 0.15 | 0.08 | 0.96 |
| EV/Net Sales(x) | 0.44 | 0.37 | 0.72 | 0.87 | 0.86 | 0.58 | 0.66 | 0.5 | 0.51 | 0.71 | 0.73 |
| EV/Core EBITDA(x) | 3.6 | 2.36 | 4.64 | 5.44 | 5.16 | 3.34 | 3.22 | 2.83 | 2.62 | 3.49 | 3.91 |
| Net Sales Growth(%) | 12.73 | 6.89 | 7.67 | 8.52 | 11.58 | 4.08 | 12.67 | 8.29 | 14.58 | 2.92 | 6.95 |
| EBIT Growth(%) | 60.92 | 23.68 | 7.02 | 3.12 | 39.13 | 4.73 | 14.24 | -22.69 | -73.41 | 508.32 | 13.01 |
| PAT Growth(%) | 72.99 | 13.82 | 8.4 | -10 | 53.94 | 7.64 | -0.2 | -37.3 | -196.33 | 319.2 | 30.02 |
| EPS Growth(%) | 72.31 | 8.26 | 9.17 | -34.23 | 123.84 | -3.65 | -38.23 | -82.84 | -2743.39 | 137.98 | 76.35 |
| Debt/Equity(x) | 0.57 | 0.41 | 0.28 | 0.26 | 0.22 | 0.4 | 0.48 | 1.07 | 1.62 | 0.46 | 0.27 |
| Current Ratio(x) | 1.29 | 1.2 | 1.57 | 1.76 | 1.71 | 1.31 | 1.54 | 1.81 | 1.55 | 1.22 | 1.07 |
| Quick Ratio(x) | 0.99 | 0.91 | 1.15 | 1.41 | 1.33 | 1.04 | 1.24 | 1.51 | 1.31 | 0.93 | 0.75 |
| Interest Cover(x) | 24.63 | 28.18 | 30.52 | 24.83 | 31.5 | 16.08 | 15.09 | 6.97 | 1.1 | 7.81 | 20.26 |
| Total Debt/Mcap(x) | 0.29 | 0.31 | 0.17 | 0.13 | 0.11 | 0.4 | 0.34 | 0.98 | 1.15 | 0.2 | 0.12 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 |
| FII | 8.49 | 8.96 | 8.87 | 9.48 | 9.64 | 9.6 | 9.33 | 9.3 | 9.42 | 9.49 |
| DII | 1.24 | 1.28 | 1.45 | 1.51 | 1.48 | 1.48 | 1.43 | 1.43 | 1.42 | 1.46 |
| Public | 16.22 | 15.71 | 15.64 | 14.97 | 14.83 | 14.87 | 15.19 | 15.23 | 15.11 | 15.01 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 |
| FII | 0.59 | 0.63 | 0.62 | 0.66 | 0.67 | 0.67 | 0.65 | 0.65 | 0.66 | 0.66 |
| DII | 0.09 | 0.09 | 0.1 | 0.11 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Public | 1.13 | 1.1 | 1.09 | 1.04 | 1.03 | 1.04 | 1.06 | 1.06 | 1.05 | 1.05 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +7% | +8% | +9% | +8% |
| Operating Profit CAGR | -3% | +10% | +10% | +13% |
| PAT CAGR | +30% | +40% | +11% | +12% |
| Share Price CAGR | -26% | +15% | +2% | +14% |
| ROE Average | +43% | +22% | +21% | +28% |
| ROCE Average | +46% | +28% | +26% | +32% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 |
| FII | 8.49 | 8.96 | 8.87 | 9.48 | 9.64 | 9.6 | 9.33 | 9.3 | 9.42 | 9.49 |
| DII | 1.24 | 1.28 | 1.45 | 1.51 | 1.48 | 1.48 | 1.43 | 1.43 | 1.42 | 1.46 |
| Public | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 | 5.17 |
| FII | 0.59 | 0.63 | 0.62 | 0.66 | 0.67 | 0.67 | 0.65 | 0.65 | 0.66 | 0.66 |
| DII | 0.09 | 0.09 | 0.1 | 0.11 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Public | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.